Pages that link to "Q33491977"
Jump to navigation
Jump to search
The following pages link to Thrombocytopenia in c-mpl-deficient mice (Q33491977):
Displaying 50 items.
- Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases (Q21296645) (← links)
- Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice (Q24290960) (← links)
- Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis (Q24309295) (← links)
- Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis (Q24316448) (← links)
- Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development (Q24321429) (← links)
- RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes (Q24533459) (← links)
- Megakaryocyte biology and related disorders (Q24536140) (← links)
- Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice (Q24652041) (← links)
- Endoreplication: polyploidy with purpose (Q24654063) (← links)
- Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia (Q24672498) (← links)
- TPO/Mpl Studies in Agnogenic Myeloid Metaplasia (Q24805242) (← links)
- The pathophysiology of thrombocytopenia in chronic liver disease (Q26749277) (← links)
- Linkage between the mechanisms of thrombocytopenia and thrombopoiesis (Q26770863) (← links)
- Pathogenesis of myeloproliferative neoplasms (Q26799656) (← links)
- Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9. (Q27333563) (← links)
- Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes (Q28142403) (← links)
- Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia (Q28145261) (← links)
- Platelet-activating factor receptor (Q28214944) (← links)
- LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors (Q28274115) (← links)
- Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis (Q28504828) (← links)
- Gene trapping of two novel genes, Hzf and Hhl, expressed in hematopoietic cells (Q28505418) (← links)
- Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2 (Q28508573) (← links)
- Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy (Q28585549) (← links)
- Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice (Q28593767) (← links)
- MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling (Q28854388) (← links)
- Hematopoietic stem cell: self-renewal versus differentiation (Q29396498) (← links)
- Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis (Q30486155) (← links)
- Analysis of thrombocyte development in CD41-GFP transgenic zebrafish (Q30796563) (← links)
- Thrombopoietin signaling is required for in vivo expansion of IL-11--responsive hematopoietic progenitor cells in the steady state. (Q31883469) (← links)
- The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5. (Q31893762) (← links)
- Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis (Q33194891) (← links)
- Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes. (Q33328243) (← links)
- Therapeutic cytokine stimulation of thrombocytopoiesis (Q33328414) (← links)
- Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity (Q33328634) (← links)
- Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells (Q33329615) (← links)
- Thrombopoietin (Q33330090) (← links)
- Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers (Q33331790) (← links)
- Pharmacologic treatment options in patients with thrombocytopenia (Q33332598) (← links)
- Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice (Q33334325) (← links)
- Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents (Q33340623) (← links)
- Molecular control of megakaryopoiesis and thrombopoiesis (Q33343081) (← links)
- Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions (Q33344528) (← links)
- Raf-1 is not required for megakaryocytopoiesis or TPO-induced ERK phosphorylation (Q33357285) (← links)
- Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis (Q33358404) (← links)
- Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes (Q33371036) (← links)
- Haematopoietic stem and progenitor cell-targeted therapies for thrombocytopenia (Q33372720) (← links)
- New insights and therapeutics for immune-mediated thrombocytopenia (Q33377901) (← links)
- Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura (Q33379498) (← links)
- Boosting platelet production (Q33381049) (← links)
- An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance (Q33382312) (← links)